Lara Goldstein - Spark Newswire - Page 28

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

2 minute read

Irwin Naturals’ Buys Holistic Clinic In Vermont, Expanding Ketamine Emergency Treatments To Northeast Area

By Lara Goldstein

Today, 8:11 PM

Irwin Naturals Inc. (OTC: IWINF), a nutraceutical company developing hemp-based CBD products, is growing its national chain of psychedelic mental health emergency clinics, Irwin Naturals Emergence, including ketamine-assisted treatments.

Read More

2 minute read

Government-Funded Smoking Cessation Trial Uses Mydecine’s New Psilocybin-Derived MYCO-001, Recently FDA-Approved

By Lara Goldstein

Today, 8:11 PM

Biotech company Mydecine Innovations Group (OTC: MYCOF) received FDA approval for their novel proprietary MYCO-001. This is the first clearance of the company’s drug product.

Read More

2 minute read

Michael Pollan’s ‘How To Change Your Mind’ Coming Soon To Netflix: Documentary Based On Psychedelics Best Seller

By Lara Goldstein

Today, 8:11 PM

The freshest news traversing many of the major institutions, researchers' and activists’ accounts on Twitter is the recent release of a docu-series based on writer Michael Pollan’s 2018 book “How To Change Your Mind: What the science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence.”

Read More

1 minute read

Ketamine-Clinics Revitalist Raises Nearly $4M In Second Round Of Private Placement

By Lara Goldstein

Today, 8:11 PM

There are two ways in which companies can raise funds: public offerings or direct sale of shares to investors, usually via private placements.

Read More

2 minute read

Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments

By Lara Goldstein

Today, 8:11 PM

For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment.

Read More

2 minute read

More Patent Applications For Psilocybin: Learn About NOVA’s Psychedelic Treatments For Neurological Diseases

By Lara Goldstein

Today, 8:11 PM

The Canadian biotech company Nova Mentis Life Science Corp. (OTCQB: NMLSF) is filing new provisional patent applications to the U.S.

Read More

2 minute read

Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders

By Lara Goldstein

Today, 8:11 PM

Mindset Pharma Inc.

Read More

2 minute read

Cybin Moves Forward With Phase 1/2a Clinical Trial For Treatment Of Major Depressive Disorder

By Lara Goldstein

Today, 8:11 PM

Cybin Inc.

Read More

1 minute read

Elon Musk Says Psychedelics Should Be Seriously Considered For Therapeutic Uses, Leading Chorus Of Celeb Support

By Lara Goldstein

Today, 8:11 PM

Elon Musk, the Tesla multi-billionaire investor and owner of the largest portion of Twitter (NYSE: TWTR) shares has been discus

Read More

2 minute read

Clinical Trials Of Psilocybin Treatment For Overeating Disorder Are Ready, Here’s What Results Show So Far

By Lara Goldstein

Today, 8:11 PM

Tryp Therapeutics Inc. (OTCQB: TRYPF) is a clinical-stage biotech company focused on developing psilocybin-based compounds for ill-treated diseases.